Criculating fibrocytes: A potent cell population in antigen-presenting and wound healing

Chinese Journal of Traumatology - English Edition

Volumn 13, Issue 2, 2010, Pages 111-116

  Fan, Xia ^a   Liang, Hua Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis inducing agents; Antigen presenting cells; Wound healing

Indexed keywords

CD11B ANTIGEN; CD32 ANTIGEN; CD34 ANTIBODY; CD45 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; MICROSOMAL AMINOPEPTIDASE; TRANSFORMING GROWTH FACTOR BETA; SCLEROPROTEIN;

ADIPOCYTE; ANGIOGENESIS; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; FIBROBLAST; FIBROSING ALVEOLITIS; HUMAN; MYOFIBROBLAST; NEPHROGENIC SYSTEMIC FIBROSIS; PHENOTYPE; PROTEIN DEGRADATION; REVIEW; SCLERODERMA; TISSUE REPAIR; WOUND HEALING; ANIMAL; ANTIGEN PRESENTATION; BONE MARROW CELL; CELL MOTION; MESENCHYMAL STEM CELL; PHYSIOLOGY; SECRETION;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; WOUND HEALING;

EID: 77955287067     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1008-1275.2010.02.010     Document Type: Article

References (42)

1. Martin P. Wound healing-aiming for perfect skin regeneration. Science 1997;276(5309):75-81. (Pubitemid 27161246)
2. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166(12):7556-7562. (Pubitemid 32525636)
3. Bucala R, Spiegel LA, Chesney J, et al. Circulation fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1(1):71-81.
4. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007;87(9):858-870. (Pubitemid 47267815)
5. Pilling D, Buckley CD, Salmon M, et al. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003;171 (10):5537-5546. (Pubitemid 37432844)
6. Pilling D, Tucker NM, Gomer RH. Aggregated IgG inhibits the differentiation of human fibrocytes. J Leukoc Biol 2006;79(6): 1242-1251. (Pubitemid 44835558)
7. Chesney J, Metz C, Stavitsky AB, et al. Regulated production of type I collagen and inflammtory cytokines by peripheral blood fibrocytes. J Immunol 1998;160(1):419-425. (Pubitemid 28116757)
8. Yang L, Scott PG, Giuffre J, et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82(9):1183-1192. (Pubitemid 35014852)
9. Varcoe RL, Mikhail M, Guiffre AK, et al. The role of the fibrocyte in intimai hyperplasia. J Thromb Haemost 2006; 4(5): 1125-1133.
10. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003;100(5):2426-2431. (Pubitemid 36297515)
11. + monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003;74(5):833-845. (Pubitemid 38040360)
12. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Rev Immunol 2005;5(12):953-964.
13. Sunderkotter C, Nikolic T, Dillon MJ, et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004;172(7):4410-4417. (Pubitemid 38375256)
14. Schmidt M, Sun G, Stacey MA, et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003;171(1):380-389. (Pubitemid 36745311)
15. Yang L, Scott PG, Dodd C, et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 2005;13(4): 398-404. (Pubitemid 41060421)
16. Pilling D, Gomer RH. Regulatory pathways for fibrocyte differentiation. Chapter 3. In: Bucala R, ed. Fibrocytes: New insights into tissue repair and systemic fibroses. Singapore: World Scientific publishing Co, 2007:37-60.
17. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15(2):81-88.
18. Vannella KM, McMillan TR, Charbeneau RP, et al. Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function. J Immunol 2007;179(11):7883-7890.
19. Hong KM, Belperio JA, Keane MP, et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 2007;282(31):22910-22920.
20. Hong KM, Burdick MD, Phillips RJ, et al. Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice. FASEB J 2005; 19(14):2029-2031.
21. Shao DD, Suresh R, Vakil V, et al. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008;83(6):1323-1333. (Pubitemid 351960310)
22. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003; 60(7):1342-1350.
23. Hjelmstorm P, Fjell J, Nakagawa T, et al. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol 2000;156(4):1133-1138. (Pubitemid 30659989)
24. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 2000;177:175-184.
25. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114(3):438-446. (Pubitemid 39071616)
26. Mehrad B, Burdick MD, Zisman DA, et al. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007;353(1):104-108. (Pubitemid 44958347)
27. Schmitt D. Immune functions of the human skin. Models of in vitro studies using Langerhans cells. Cell Biol Toxicol 1999; 15(1):41-45.
28. Chesney J, Bacher M, Bender A, et al. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA 1997;94(12): 6307-6312. (Pubitemid 27270680)
29. Geppert TD, Lipsky PE. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable la expression. J Immunol 1985;135(6):3750-3762.
30. Balmelli C, Ruggli N, McCullough K, et al. Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J Leukoc Biol 2005;77(6):923-933. (Pubitemid 40770844)
31. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000;5(1):40-46.
32. Hartlapp I, Abe R, Saeed RW, et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001;15(12):2215-2224. (Pubitemid 32927939)
33. Salo T, Makela M, Kylmaniemi M, et al. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 1994;70(2):176-182. (Pubitemid 24090099)
34. Cowper SE, Su LD, Bhawan J, et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001;23(5):383-393.
35. + cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis. Br J Dermatol 2004;150(5):1050-1052. (Pubitemid 38903558)
36. Jimenez SA, Artlett CM, Sandorfi N, et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta 1 expression in affected skin. Arthritis Rheum 2004; 50(8):2660-2666. (Pubitemid 39062729)
37. Mendoza FA, Artlett CM, Sandorfi N, et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 2006; 35(4):238-249. (Pubitemid 43185214)
38. Choi ES, Pierce EM, Jakubzick C, et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopatic interstitial pneumonia. J Clin Pathol 2006; 59(1):28-39. (Pubitemid 43076236)
39. Mehrad B, Burdick MD, Zisman DA, et al. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007; 353(1):104-108. (Pubitemid 44958347)
40. Pierce EM, Carpenter K, Jakubzick C, et al. Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J 2007;29(6):1082-1093. (Pubitemid 46895366)
41. Katebi M, Fernandez P, Chan ES, et al. Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. Inflammation 2008;31(5):299-303.
42. Mori L, Bellini A, Stacey MA, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005;304(1):81-90. (Pubitemid 40222079)